Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Articles by Shirley Pulawski
Investing in Stocks & Retirement
Advertiser Disclosure: We believe by providing tools and education we can help people optimize their finances to regain control of their future. While our articles may include or feature select companies, vendors, and products, our approach to compiling such is equitable and unbiased. The content that we create is free and independently-sourced, devoid of any paid-for promotion. This content is not provided or commissioned by the bank advertiser.
8 Tips to Secure Assets of Aging Parents
Unfortunately the time will come where many of us have to face difficult, uncomfortable situations. One of those uncomfortable situations: securing and managing the assets of your aging parents. Age-related health issues in a parent or parents, and the potentially awkward but highly necessary discussions need to be confronted, sooner rather than later.
Etanercept efficacy may not be dependent on methotrexate background therapy
Improvements in disease activity in patients with rheumatoid arthritis who were treated with etanercept were not related to the dosage of background therapy with methotrexate, according to an analysis of results of two clinical trials. Researchers analyzed the data from the Combination of Methotrexate and Etanercept in Active Early Rheumatoid Arthritis results (COMET) and Trial of Etanercept and Methotrexate with Radiographic Patient Outcomes (TEMPO) studies.
Speaker: Glucocorticoid-induced osteoporosis risks are undetermined
CHICAGO – Glucocorticoid-induced osteoporosis and associated fractures are not uncommon, but avoidable, according to a speaker here at the at the American College of Rheumatology State of the Art Clinical Symposium. Kenneth G. Saag, MD, MSc, said testing with dual-energy X-ray absorptiometry (DXA) scanning can be an important monitoring tool, but getting insurance reimbursement for regular testing, such as every 6 months for patients who chronically take glucocorticoids, can be difficult.
Young patients with arthritis aspire to have ‘normal’ lives
A sustainable balance between the emotional, social and vocational aspects of treatment with young patients between the ages of 16 and 25 years with arthritis “Young people can have severe arthritis, warranting aggressive treatment, but may find such regimens a struggle to sustain.
Study: Undetectable joint progression in patients with RA may be rare
About 5.8% of patients with rheumatoid arthritis had undetected joint progression compared with 43% of studied patients who had radiographic progression during a 3-year to 5-year observation period, according to results of a recently published study. Researchers studied 279 patients with rheumatoid arthritis who had radiographs of up to 22 hand and wrist joints during the observation period. All images were scored using the Sharp van der Heijde score (SHS) and compared by the same interpreter.
Feldman discusses improving adherence to treatment
NEW YORK – At the interdisciplinary Autoimmune Summit, Steven R. Feldman, MD, PhD, a dermatologist at Wake Forest University Hospital in Winston-Salem, N.C., discussed strategies to improve adherence to medications and how his team has studied the issues of compliance to medication dosing and schedules.
Immune system, response to vaccines may be modulated by sleep activity
NEW YORK CITY — During a presentation at the Interdisciplinary Autoimmune Summit, Aric A. Prather, PhD, said sleep plays a role in modulating the immune system and a lack of adequate sleep can lower response to vaccination and resistance to infection. Prather said sleep is a dynamic process, and cycles of rapid-eye movement and other types of sleep, including slow-wave sleep, normally occur many times throughout the night in people who are healthy sleepers.
Husni discusses the use of MRI, detailed patient history in the identification of SpA
HOLLYWOOD, Fla. — At the Fourth Annual Basic and Clinical Immunology for the Busy Clinician, M. Elaine Husni, MD, MPH, discussed the use of MRI in the identification of bone marrow edema and other non-radiographic features of spondyloarthropathies. Husni said the current treatment goal is to identify the disease earlier. She noted the Assessment of Spondyloarthritis International Society criteria addresses this goal, even in cases without radiographic progression.
Silverman talks new treatments, pathogenesis of SLE
NEW YORK CITY— The elimination of B cells may be the key to controlling disease activity for patients with systemic lupus erythematosus, although the disease is heterogeneous, according to a speaker here. Gregg J. Silverman, MD, discussed new treatment opportunities and the pathogenesis of systemic lupus erythematosus (SLE) at the Interdisciplinary Autoimmune Summit.
Pharmacodynamics of biologic therapies across disciplines highlighted at IAS
NEW YORK CITY — Diane R. Mould, PhD, president of Projections Research Inc. discussed pharmacodynamics in the use of biologic therapies in rheumatic, gastroenterological and dermatologic diseases here at the Interdisciplinary Autoimmune Summit. “The idea is about trying to learn about the factors that impact these different concentrations,” Mould said. “With any drug, it is not the dose you prescribe.
Katz discusses autoimmune diseases from a multidisciplinary perspective
NEW YORK CITY — Stephen I. Katz, MD, PhD, director of the National Institute of Arthritis and Musculoskeletal and Skin Diseases at the NIH, presented the keynote speech at the Interdisciplinary Autoimmune Summit and urged rheumatologists, dermatologists, gastroenterologists and other health care professionals who treat patients with autoimmune diseases to work together. He also discussed the future work of NIH research into autoimmune diseases from a multidisciplinary approach.
Rheumatoid factor, disease activity may predict lymphoma in primary Sjögren’s syndrome
The presence of rheumatoid factor and level of disease activity may be risk factors for the development of lymphoma in patients with primary Sjögren’s syndrome, according to recently published research. Researchers studied 101 patients with primary Sjögren’s syndrome and lymphoma, 86.1% of whom were women with a mean age of 57.4 years at lymphoma diagnosis.
Higher risk for MI after joint surgery seen among patients with RA
A higher risk for myocardial infarction was seen in patients with rheumatoid arthritis following joint surgery, according to the results of a retrospective cohort study. Researchers analyzed data from 308,589 joint surgeries among 240,571 patients. Of these, 3,654 patients had rheumatoid arthritis (RA). Patients were admitted to hospitals in the Australian state of Victoria, and records were maintained by the Victorian Department of Health and Human Services.
Incidence of PsA among patients with psoriasis may be higher than estimated
Previous estimates on the incidence of psoriatic arthritis among patients with psoriasis may not accurately reflect the prevalence of disease, according to recently published research that noted patients with uveitis, nail pitting and low levels of education may have a higher risk for developing psoriatic arthritis. Researchers studied data from 464 patients who participated in the Toronto Psoriasis Cohort and had a dermatologist-confirmed diagnosis of psoriasis.
Patients with gout may benefit from arhalofenate
Gout flares were significantly decreased in patients who received 800-mg arhalofenate compared with 300-mg allopurinol, according to recently published data. Researchers studied data from 239 patients with gout who received at least one dose of study medication. Of the patients, 95.8% were male. Investigators found the mean baseline serum uric acid level was 9.1 mg/dL. Tophi was found in 20.1% of patients.
Response to cyclophosphamide may have genetic link for patients with lupus nephritis
The FCGR2B-FCRLA locus was associated with response to treatment with cyclophosphamide by patients with lupus nephritis, according to results of a study in which investigators used a genome-wide association approach. Researchers studied 109 Korean patients recruited from the Hanyang University Hospital for Rheumatic Diseases in Seoul, Korea. Patients had systemic lupus erythematosus and lupus nephritis, with greater than 500 mg/day proteinuria.
Remission, minimal disease activity may be possible with TNFi for some patients with axial PsA
Some patients with axial psoriatic arthritis were able to achieve minimal disease activity and remission with tumor necrosis factor inhibitors, according to the results of a study. Researchers recruited 58 patients with predominant axial psoriatic arthritis and a median disease duration of 8.05 years. Dactylitis was present in 17 patients, and 12 patients had enthesitis. Investigators found 13 patients were HLA-B27-positive.
Study: Paracetamol not efficacious for treatment of osteoarthritis pain
According to researchers, paracetamol is not effective for the treatment of osteoarthritis pain regardless of dose, and patients responded more favorably to treatment with 150-mg diclofenac. Researchers analyzed the Cochrane Central Register of Controlled Trials (CENTRAL) for data published from osteoarthritis (OA) trials between Jan. 1, 1980 and Feb. 24, 2015.
Osteoporotic fracture risk may be overestimated using the UK FRAX algorithm for patients with RA
An overestimation of the fracture risk for patients with rheumatoid arthritis compared to the general population was found using the U.K. fracture risk assessment tool for predicting the 10-year risk of hip or other major osteoporotic fracture, according to recently published data.
High rate of drug survival, reduced glucocorticoid use seen with TNFi for patients with PsA
Patients with psoriatic arthritis who received tumor necrosis factor inhibitors, including adalimumab, etanercept and infliximab, had a high likelihood of drug continuation and reduced use of glucocorticoids after 4 years, according to recently published data. Researchers analyzed data from 420 patients with psoriatic arthritis who initiated treatment with tumor necrosis factor inhibitors adalimumab, etanercept and infliximab.
Combo rheumatology, dermatology clinic linked with increased patient satisfaction
Results of a patient survey conducted at the Dermatology and Rheumatology Treatment Clinic in Vancouver, Canada, show that most patients found it beneficial to see both a dermatologist and rheumatologist in a combined location. One hundred surveys were distributed to patients at the Dermatology and Rheumatology Treatment (DART) Clinic with 23 questions related to the quality and timeliness of patient visits.
High incidence of pruritus found among patients with primary Sjögren’s syndrome
Patients with primary Sjögren’s syndrome may have a high incidence of pruritus that may negatively impact sleep and quality of life, according to recently presented data. Researchers surveyed 20 patients with primary Sjögren’s syndrome who met the American College of Rheumatology criteria, and underwent rheumatologic and dermatologic evaluations between February 2014 and March 2015. Patients had a mean age of 55 years and 17 were women.
New certification for nurses with specialization in rheumatology may help fill treatment gaps
A new certification for nurses who specialize in rheumatology has been developed by a credentialing board and a society of nurses to fulfill unmet needs in rheumatologic care.
Certolizumab pegol may relieve RA symptoms, reduce methotrexate use
Analysis of pooled data from two phase 3 studies of patients with rheumatoid arthritis treated with methotrexate and certolizumab pegol at 200-mg or 400-mg doses or placebo every 2 weeks showed symptom relief in the treatment groups compared to placebo, regardless of methotrexate dose. Researchers studied data from the Rheumatoid Arthritis Prevention of Structural Damage 1 (RAPID 1) and RAPID 2 randomized, double-blind, placebo-controlled trials of 1,598 patients with available data.
Bone marrow edema may improve with NSAIDs for patients with axial spondyloarthritis
Dropout rates from the use of full-dose NSAIDs were high among patients with axial spondyloarthritis, and while no clinical difference was seen in certain ratings of disease activity between patients who continued NSAIDs and patients who did not, bone marrow edema of the sacroiliac joints was reduced after 6 weeks in newly diagnosed patients, according to recently published research.
Cementless TKA may provide successful outcomes for patients with late RA
Total knee arthroplasty performed with a posterior-stabilized cementless prosthesis in patients with late-stage rheumatoid arthritis resulted in improved functional scores and increased range of motion with a high level of aseptic survivorship, according to study results presented this week. Researchers analyzed outcome data from 102 patients with rheumatoid arthritis (RA) with a mean age of 67 years and mean BMI of 32 kg/m2. Thirty patients were men and 72 were women.
Multibiomarker disease activity score may predict radiographic progression in patients with RA
Radiographic progression was lower in patients with rheumatoid arthritis and a low multibiomarker disease activity score compared to measurements of C-reactive protein, erythrocyte sedimentation rate or disease activity score of 28 joints, according to recently published research.
Tocilizumab may help patients with RA with poor response to methotrexate
The administration of tocilizumab in combination with methotrexate may be more effective than tocilizumab monotherapy for patients who did not adequately respond to methotrexate, according to recently published research. A group of 223 patients with moderate to severe rheumatoid arthritis (RA) were randomized to either a group of patients switched from methotrexate to tocilizumab (Actemra, Genentech) or who received methotrexate plus tocilizumab for 2 years.
Oral contraceptives may be protective against progression of inflammatory arthritis
Past and current use of oral contraceptives appeared to have a protective effect with better patient-reported outcomes in patients with inflammatory arthritis, according to recently published research. Researchers studied data from 273 women with rheumatoid arthritis (RA) and were enrolled in the Course and Prognosis of Early Arthritis cohort.
Patients with SLE, multiple CT scans may have a higher risk for malignancy
Patients with systemic lupus erythematosus with chest pain may undergo multiple CT scans for pulmonary embolism, and while multiple scans were associated with a lower likelihood of positive results and a higher risk for malignancy, researchers suggest the magnitude of risk should not discourage the use of CT when clinically indicated.
Patients with Sjögren’s syndrome and certain antibodies have greater disease activity
Disease activity was higher in patients with Sjögren’s syndrome who also had certain autoantibodies, which were significantly associated with the presence of anti-Ro60, anti-Ro52, anti-La, rheumatoid factor and hypergammaglobulinemia, as well as higher ocular surface staining scores, lower Schirmer’s test scores and minor labial salivary gland biopsy focus scores of 3 or higher, according to recently published research.
Risk of hepatitis B reactivation low in patients with RA treated with rituximab
Patients with rheumatoid arthritis and resolved hepatitis B virus infection who underwent treatment with rituximab did not experience reactivation of the infection, according to results of a multicenter Italian study. Researchers retrospectively studied data from 306 consecutive patients with rheumatoid arthritis (RA) who received treatment with rituximab (Rituxan, Genentech/Biogen Idec).
Minimal disease activity predicted outcomes with golimumab for patients with PsA
Patients with psoriatic arthritis who met minimal disease activity with golimumab treatment at three or four consecutive visits were more likely to have better long-term outcomes and less radiographic progression than patients who did not meet minimal disease activity criteria, according to recently published research. A group of 405 patients with psoriatic arthritis were enrolled in the GO-REVEAL trial.
Low disease activity persists for some patients with RA after halting adalimumab
A large proportion of patients with rheumatoid arthritis remained in a state of low disease activity after discontinuation of adalimumab, while continuing methotrexate as a monotherapy, according to recently published research.
BMD improved with etanercept in patients with AS, but fracture risk remained
Patients with ankylosing spondylitis had improvements in bone mineral density after treatment with etanercept, but the risk for fracture remained high, according to researchers at the Jan van Breemen Research Institute/Reade in Amsterdam. A group of 49 patients with ankylosing spondylitis were enrolled at initiation of etanercept (Enbrel, Amgen). All patients were naïve to other biologic treatments. Overall, 82% of patients were men.
Clinical trial approved in UK for biosimilar to rituximab for RA
JHL Biotech Inc. announced the United Kingdom’s Medicines and Healthcare Products Regulatory Agency has authorized the company to begin a clinical trial for JHL1101, a biosimilar to rituximab, for patients with rheumatoid arthritis, according to a company press release. The randomized, double-blind phase 1 trial is expected to begin later this year and will evaluate the safety and efficacy, as well as the pharmacokinetic and pharmacodynamic similarity, of JHL1101 to rituximab (MabThera, Roche).
Reduction, removal of glucocorticoids possible under abatacept therapy for RA
Patients with rheumatoid arthritis who received treatment with abatacept were able to reduce the use of concomitant glucocorticoids or cease their use altogether, according to results from the 2-year ACTION study. Researchers studied the results from the ACTION (AbataCepT In rOutiNe clinical practice) non-interventional cohort study, which included 1,137 patients with rheumatoid arthritis (RA).
Researchers identify prognostic factors for spondyloarthritis outcomes
Low educational level, older age, high disease activity at onset, positive smoking status and female sex were prognostic features of bad functional outcomes in patients with early inflammatory back pain, according to researchers in France.
What to do with $500
Smart spending is about making your purchases work for you. Sure, you could drop $500 on improving your work wardrobe in hopes of landing a raise or use it to have some fun and buy the latest iPhone which you could argue would help you manage your life, but there are better ways to spend. Obviously, if you have a lot of high-interest credit card debt, using $500 to pay some of that down is a good idea, but if your debt is in check, here are some other smart strategies on what to do with $500.
8 Big Saving Tips for the Holidays
Advertiser Disclosure: We believe by providing tools and education we can help people optimize their finances to regain control of their future. While our articles may include or feature select companies, vendors, and products, our approach to compiling such is equitable and unbiased. The content that we create is free and independently-sourced, devoid of any paid-for promotion. This content is not provided or commissioned by the bank advertiser.
Drowning In Debt? 4 Crucial Questions to Ask Before Refinancing Your Home
Advertiser Disclosure: Many of the offers appearing on this site are from advertisers from which this website receives compensation for being listed here. Compensation may be earned on this website when a customer clicks on a link, when an application is approved, or when an account is opened. This compensation may impact how and where products appear on this site (including, for example, the order in which they appear). These offers do not represent all account options available.
Shopaholics: Mental Tips to Stop Overspending
Some people dread shopping and spending money, but some of us really enjoy shopping… a lot. Some of us love to find bargains, be the first to jump onto new trends, have collections we like to grow, or just like the short-lived thrill we get when a new bauble catches our eye and we get to take it home. For those of us who really like to shop and buy new things, credit cards can provide a ticket to shopping bliss, but also lead us down the road to financial catastrophe.
How Student Loan Debt Can Affect a Mortgage Application
Could student loan debt be holding back many Americans from getting approved for a mortgage? For many people, student loan debt is one of the largest outstanding debts they’ll ever have besides a mortgage. Even though the payments may be designed to be affordable, the large lump sum can make a potential buyer’s creditworthiness seem lower, which is why it can be harder sometimes to get a mortgage when you have student loan debts.
How to Use Home Equity Loan to Buy a Second Home
Buying a second home can open up many possibilities for families, including access to new jobs, more comfortable vacations, and options for rental incomes, among others. While several means for buying a second home exist, such as obtaining a typical mortgage or selling off investments, another way to manage the purchase of a second home is to use the equity in your current home to pay for the second home or condo.
Are Moving Expenses Tax Deductible? Who Can Claim in 2026
Wondering if moving expenses are tax deductible? If you’ve relocated recently, the answer has likely been “no” since 2018. The Tax Cuts and Jobs Act eliminated this deduction for most taxpayers, leaving many without this valuable tax break. However, this tax benefit isn’t gone forever. The moving expenses deduction is set to return in 2025 when the current tax law provisions expire. At that point, many taxpayers will once again qualify to deduct their moving costs when filing federal returns.
Show More
loading
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with Shirley
Contact Shirley, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack